Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas

Cynthia R. Boschman, Steven Stryker, Janardan K. Reddy, M. Sambasiva Rao*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

119 Scopus citations


To evaluate the incidence and stage at which p53 alterations occur in human pancreatic carcinogenesis, we examined primary and metastatic carcinomas, carcinoma in situ, and hyperplastic lesions with and without atypia for p53 protein overexpression by immunohistochemical procedure. Overexpression of p53 was observed in 40% (10/25) of primary tumors, 29% (2/7) of metastatic tumors, 36% (5/14) of carcinoma in situ, and 35% (6/17) of hyperplastic lesions. These results suggest that p53 protein overexpression is not only a common genetic alteration but also occurs very early in the development of these tumors. It is suggested that p53 overexpression can be used as a marker to identify precursor lesions that have increased potential to develop into malignant tumors.

Original languageEnglish (US)
Pages (from-to)1291-1295
Number of pages5
JournalAmerican Journal of Pathology
Issue number6
StatePublished - Dec 1 1994

ASJC Scopus subject areas

  • Pathology and Forensic Medicine


Dive into the research topics of 'Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas'. Together they form a unique fingerprint.

Cite this